(0.25%) 5 112.93 points
(0.28%) 38 347 points
(0.28%) 15 973 points
(-0.94%) $83.06
(5.51%) $2.03
(0.37%) $2 355.90
(0.42%) $27.65
(3.95%) $958.55
(-0.21%) $0.933
(-0.37%) $10.98
(-0.52%) $0.796
(1.69%) $93.43
Live Chart Being Loaded With Signals
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States...
Stats | |
---|---|
本日の出来高 | 8 393.00 |
平均出来高 | 31 482.00 |
時価総額 | 11.17M |
EPS | $0 ( 2023-08-29 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -15.96 |
ATR14 | $0.0300 (1.29%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2004-08-24 | Patou Gary | Sell | 2 500 | Stock Options |
2004-08-25 | Patou Gary | Sell | 5 500 | Stock Options |
2004-07-01 | Hennessey Robert J | Sell | 1 500 | Stock Options |
2004-06-29 | Kirby Pamela J | Buy | 9 047 | Stock Options(right to buy) |
2004-06-29 | Kirby Pamela J | Buy | 25 000 | Stock Options(right to buy) |
INSIDER POWER |
---|
0.00 |
Last 92 transactions |
Buy: 380 693 | Sell: 1 344 573 |
Genetic Technologies Ltd 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Genetic Technologies Ltd 財務諸表
Annual | 2023 |
収益: | $8.69M |
総利益: | $4.35M (50.09 %) |
EPS: | $-0.120 |
FY | 2023 |
収益: | $8.69M |
総利益: | $4.35M (50.09 %) |
EPS: | $-0.120 |
FY | 2022 |
収益: | $6.79M |
総利益: | $6.47M (95.27 %) |
EPS: | $-0.0773 |
FY | 2021 |
収益: | $120 554 |
総利益: | $-240 473 (-199.47 %) |
EPS: | $-48.00 |
Financial Reports:
No articles found.
Genetic Technologies Ltd
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include cardiovascular, type 2 diabetes, prostate cancer, and melanoma. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。